Electrochemical Biosensor Label-Free Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current point-of-care (POC) systems for monitoring physiological variables are limited by portability, cost, analysis time, and the need for skilled personnel, making them unsuitable for miniaturized automated applications, and existing methods like ELISA and high-performance liquid chromatography are not well-suited for miniaturized systems.
Innovation Solution
Integration of biosensors into microfluidic devices for electrochemical detection, using a sensing electrode with a binding agent that forms a binding agent-analyte complex, altering electron transfer properties, allowing for specific and sensitive detection of analytes with simple electrical circuits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If ELISA and high-performance liquid chromatography are used for monitoring physiological variables, then measurement precision is improved, but device complexity and portability are worsened
Solution Approach 1:
The patent replaces complex mechanical and chemical laboratory systems (ELISA, HPLC) with an electrochemical sensing system that uses electrical signals for detection. The electrochemical biosensor converts biochemical interactions directly into measurable electrical signals, eliminating the need for complex mechanical chromatography systems or multi-step ELISA procedures, thereby reducing device complexity while maintaining detection capability
Solution Approach 2:
The patent changes the detection parameter from optical or chemical readouts to electrical signals. By measuring electrochemical parameters (current, voltage, impedance) instead of optical density or chemical separation, the system achieves simplified device architecture while preserving measurement precision for physiological variable monitoring
2Measurement precision
If laboratory techniques are used for physiological monitoring, then measurement precision is improved, but analysis time is worsened
Solution Approach 1:
The electrochemical detection method replaces time-consuming mechanical and chemical processes with rapid electrical measurements. The direct transduction of biochemical interactions into electrical signals occurs in real-time or near real-time, eliminating lengthy incubation, washing, and detection steps inherent in ELISA and HPLC, thus significantly reducing analysis time while maintaining precision
Solution Approach 2:
The electrochemical biosensor enables continuous or near-continuous monitoring of physiological variables. The system can perform repeated measurements without requiring complete dismantling or extensive preparation between tests, allowing for dynamic tracking of analyte concentrations over time with minimal interruption, thereby reducing total analysis time
3Measurement precision
If current sensing systems are used in diagnostic laboratories, then measurement precision is improved, but ease of operation is worsened
Solution Approach 1:
The electrochemical system replaces complex laboratory instrumentation with a simplified electrical measurement platform. The direct conversion of biochemical events to electrical signals eliminates the need for skilled operators to manage complex mechanical systems, multiple reagent additions, and sophisticated data processing, making the system easier to operate while preserving detection accuracy
Solution Approach 2:
The electrochemical biosensor performs self-detection through automatic signal generation from the binding event itself. The analyte-binding process directly modulates the electrical signal without requiring external intervention or complex processing steps, reducing the need for skilled personnel and simplifying operation to basic electrical measurement
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, sensitive, and automated detection of analytes in a miniaturized format, reducing errors associated with human handling and improving diagnostic capabilities at the point of care.
Implementation Method 1
the binding of the analyte to the binding agent alters the electron transfer properties at the sensing electrode surface thereby providing a change in the electrochemical response
Data Source
AI summary
The current invention pertains to electrochemical biosensors. The electrochemical biosensor of the current invention comprises:a) a sensing electrode having attached to its surface a binding agent capable of specifically binding to the analyte to form a binding agent-analyte complex and wherein the binding of the analyte to the binding agent alters the electron transfer properties at the sensing electrode surface thereby providing a change in the electrochemical response at the sensing electrode surface proportional to the number of binding agent-analyte complexes, andb) a test equipment capable of measuring the electrochemical response at the sensing electrode surface.The binding agent can be a binding protein, an antibody, or an aptamer, and the analyte can be a biomolecule. Accordingly, the current invention provides a method of detecting the presence or assessing the likelihood of development of a disease associated with an abnormal level of a biomolecule in a subject.